UA startup company Botanisol has been awarded a National Institutes of Health (NIH) and National Center for Complementary and Integrative Health (NCCIH) grant totaling almost $225,000 to develop a new anti- inflammatory drug, TAI-LCx. The novel drug represents a possible replacement for non-steroidal anti-inflammatory drugs (NSAIDs).
In this report, we show how leveraging the UA’s emerging excellence in technology transfer, commercial feasibility studies, corporate relations, and tech parks has produced an ecosystem that encourages partnerships across industries and communities, propels cycles of innovation, and actively supports entrepreneurs as they bring new products to market.
Codelucida, co-founded by a UA doctoral student and his advisors in Electrical and Computer Engineering, is developing a disruptive error-correction technology for next-generation solid-state drives (SSD). The two-year grant is non-dilutive federal funding meant to further assist the company in its commercialization efforts.
Over the past two years, a number of changes have occurred both inside TLA and within the greater University community that effect the University innovation ecosystem. With help and input from across the TLA organization, we have re-structured over the summer of 2015. Come and re-meet us.
Online employee fraud costs businesses across the globe $3.5 trillion annually. For governments, detecting digital deception is not only a matter of efficiency, but of national security. In response, a UA Eller College of Management professor has worked with TLA to patent a new software and is commercializing it via a startup company, Neuro-ID.
In completing its second full year of operations, Tech Launch Arizona reports that as of the fiscal year’s June 30 close, it has achieved all of its performance metrics defined by the Arizona Board of Regents (ABOR). In support of the UA Never Settle strategic plan, these metrics not only represent increases over theprevious year, but also all-time highs for Arizona’s 21st century land-grant university.
The Department of Chemistry and Biochemistry (CBC) at the UA College of Science has long been a powerhouse in research. Having built a close partnership with Tech Launch Arizona (TLA), it is now the University’s leading producer of intellectual property.
The University is among a select group of 18 institutions to be recognized by the Association of Public and Land-grant Universities (APLU). The designation acknowledges those working in their states and regions to support economic development through a variety of activities.
University of Arizona startup company Synactix Pharmaceuticals, Inc. has licensed a novel cancer treatment technology developed through research at the UA College of Pharmacy. The technology zeroes in on a dual kinase inhibitor that blocks two factors involved in cancer survival: oncogene addiction and vascular growth.